Skip to main content

Squarepoint Ops LLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1642575 NEW YORK, NY

Position in AGIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,917,431
+$4,850,750 QoQ
Shares Held
321,138
+53.7% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#43
of 238 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Sep 30, 2024
CallValue
$1,199,610
CallShares
27,000
PutValue
$1,199,610
PutShares
27,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. AGIO ranks #29 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AGIO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,917,431 321,138
2026-03-31 $7,066,681 208,888
2025-12-31 $3,314,388 121,763
2025-03-31 $1,111,056 37,920
2024-12-31 $5,336,956 162,415
2024-09-30 $1,199,610 27,000
2024-09-30 $1,199,610 27,000
2024-06-30 $285,540 6,622
2024-06-30 $1,164,240 27,000
2024-06-30 $1,164,240 27,000
2024-03-31 $3,276,809 112,066
2023-12-31 $755,532 33,926
2023-09-30 $423,398 17,107
2023-03-31 $251,659 10,956
2022-12-31 $722,526 25,731
2022-09-30 $485,511 17,168
2022-06-30 $2,243,404 101,191
2022-03-31 $1,000,568 34,372
2021-12-31 $1,401,215 42,629
2020-12-31 $4,482,661 103,454
2020-09-30 $4,599,210 131,406
2020-03-31 $873,872 24,630